tradingkey.logo
tradingkey.logo
Search

Rallybio Corp

RLYB
Add to Watchlist
15.930USD
-0.140-0.87%
Close 07-31 16:00ETQuotes delayed by 15 min
83.50MMarket Cap
LossP/E TTM

RLYB Income Statement

You can find the annual or quarterly income statement of Rallybio Corp here for insights into the performance and operational efficiency of Rallybio Corp.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q3
Total revenue
0.00%212.00K
484.21%222.00K
-29.10%212.00K
-29.10%212.00K
--212.00K
--38.00K
--299.00K
--299.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
0.00%212.00K
484.21%222.00K
-29.10%212.00K
--212.00K
--212.00K
--38.00K
--299.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
-9.48%8.95M
-43.04%6.63M
-42.28%7.14M
-40.76%10.27M
-50.06%9.88M
-44.84%11.65M
-36.14%12.37M
-13.69%17.33M
7.69%19.79M
23.53%21.11M
2.67%19.36M
14.01%20.08M
28.33%18.37M
38.80%17.09M
88.96%18.86M
67.28%17.61M
11.65%14.32M
--12.31M
48.75%9.98M
--10.53M
--12.82M
--6.71M
R&D expenses
-49.85%2.87M
-50.51%3.65M
-49.72%4.14M
-53.08%6.07M
-55.74%5.72M
-53.62%7.38M
-37.99%8.24M
-1.40%12.95M
15.48%12.94M
47.54%15.92M
9.73%13.29M
29.51%13.13M
46.47%11.20M
77.11%10.79M
144.15%12.11M
48.69%10.14M
-15.37%7.65M
--6.09M
-3.31%4.96M
--6.82M
--9.04M
--5.13M
Depreciation, depletion, and amortization
-89.29%3.00K
-90.00%3.00K
9.38%35.00K
-23.53%26.00K
-20.00%28.00K
-16.67%30.00K
-13.51%32.00K
-10.53%34.00K
-10.26%35.00K
-7.69%36.00K
-11.90%37.00K
-13.64%38.00K
-7.14%39.00K
11.43%39.00K
61.54%42.00K
76.00%44.00K
82.61%42.00K
--35.00K
--26.00K
--25.00K
--23.00K
----
Operating profit
9.69%-8.73M
44.76%-6.41M
42.61%-6.92M
40.96%-10.06M
51.13%-9.67M
45.02%-11.61M
37.69%-12.07M
15.18%-17.04M
-7.69%-19.79M
-23.53%-21.11M
-2.67%-19.36M
-14.01%-20.08M
-28.33%-18.37M
-38.80%-17.09M
-88.96%-18.86M
-67.28%-17.61M
-11.65%-14.32M
---12.31M
-48.75%-9.98M
---10.53M
---12.82M
---6.71M
Net non-operating interest income (expenses)
Non-operating interest income
-68.79%201.00K
-30.95%560.00K
-53.14%462.00K
-54.24%523.00K
-49.53%644.00K
-43.99%811.00K
-36.18%986.00K
-28.92%1.14M
-17.46%1.28M
35.20%1.45M
194.29%1.54M
495.56%1.61M
1493.81%1.55M
8825.00%1.07M
4275.00%525.00K
1976.92%270.00K
470.59%97.00K
--12.00K
-71.43%12.00K
--13.00K
--17.00K
--42.00K
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
--10.00K
--13.00K
Special income (expenses)
100.00%0.00
100.00%0.00
100.00%0.00
41.07%-287.00K
14.31%-587.00K
29.85%-430.00K
1.70%-637.00K
-124.42%-487.00K
-21.67%-685.00K
-186.45%-613.00K
-387.22%-648.00K
35.80%-217.00K
-44.36%-563.00K
4.04%-214.00K
59.94%-133.00K
27.78%-338.00K
19.09%-390.00K
---223.00K
36.88%-332.00K
---468.00K
---482.00K
---526.00K
Other non-operating income (expenses)
45.98%254.00K
-100.00%0.00
8855.78%22.48M
-17.48%118.00K
4.19%174.00K
422.86%183.00K
172.83%251.00K
130.65%143.00K
128.77%167.00K
12.90%35.00K
-6.12%92.00K
-38.00%62.00K
-35.40%73.00K
-71.56%31.00K
-6.67%98.00K
170.42%100.00K
370.83%113.00K
--109.00K
101.92%105.00K
---142.00K
--24.00K
--52.00K
Income before tax
12.30%-8.28M
47.01%-5.85M
239.68%16.02M
40.24%-9.70M
50.40%-9.44M
45.44%-11.04M
37.60%-11.47M
12.85%-16.24M
-9.88%-19.03M
-24.93%-20.24M
-0.02%-18.37M
-5.95%-18.63M
-19.45%-17.32M
-30.51%-16.20M
-80.17%-18.37M
-58.02%-17.58M
-9.21%-14.50M
---12.41M
-42.50%-10.20M
---11.13M
---13.28M
---7.16M
Income tax
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
12.30%-8.28M
47.01%-5.85M
239.68%16.02M
40.24%-9.70M
50.40%-9.44M
45.44%-11.04M
37.60%-11.47M
12.85%-16.24M
-9.88%-19.03M
-24.93%-20.24M
-0.02%-18.37M
-5.95%-18.63M
-19.45%-17.32M
-30.51%-16.20M
-80.17%-18.37M
-58.02%-17.58M
-9.21%-14.50M
---12.41M
-42.50%-10.20M
---11.13M
---13.28M
---7.16M
Net income from continuous operations
12.30%-8.28M
47.01%-5.85M
239.68%16.02M
40.24%-9.70M
50.40%-9.44M
45.44%-11.04M
37.60%-11.47M
12.85%-16.24M
-9.88%-19.03M
-24.93%-20.24M
-0.02%-18.37M
-5.95%-18.63M
-19.45%-17.32M
-30.51%-16.20M
-80.17%-18.37M
-58.02%-17.58M
-9.21%-14.50M
---12.41M
-42.50%-10.20M
---11.13M
---13.28M
---7.16M
Net income attributable to controlling interests
12.30%-8.28M
47.01%-5.85M
239.68%16.02M
40.24%-9.70M
50.40%-9.44M
45.44%-11.04M
37.60%-11.47M
12.85%-16.24M
-9.88%-19.03M
-24.93%-20.24M
-0.02%-18.37M
-5.95%-18.63M
-19.45%-17.32M
-30.51%-16.20M
-80.17%-18.37M
-58.02%-17.58M
-9.21%-14.50M
---12.41M
-42.50%-10.20M
---11.13M
---13.28M
---7.16M
Net income attributable to common shareholders
12.30%-8.28M
47.01%-5.85M
239.68%16.02M
40.24%-9.70M
50.40%-9.44M
45.44%-11.04M
37.60%-11.47M
12.85%-16.24M
-9.88%-19.03M
-24.93%-20.24M
-0.02%-18.37M
-5.95%-18.63M
-19.45%-17.32M
-30.51%-16.20M
-80.17%-18.37M
-58.02%-17.58M
-9.21%-14.50M
---12.41M
-42.50%-10.20M
---11.13M
---13.28M
---7.16M
Basic earnings per share
-590.29%-1.46
-316.51%-1.03
1205.94%2.84
41.19%-0.22
54.83%-0.21
50.36%-0.25
43.28%-0.26
20.28%-0.37
-8.47%-0.47
-9.42%-0.50
24.05%-0.45
19.71%-0.46
10.02%-0.43
-10.14%-0.46
-61.14%-0.60
79.45%-0.57
88.37%-0.48
---0.41
-14.62%-0.37
---2.80
---4.11
---0.32
Diluted earnings per share
-590.29%-1.46
-316.51%-1.03
1205.94%2.84
41.19%-0.22
54.83%-0.21
50.36%-0.25
43.28%-0.26
20.28%-0.37
-8.47%-0.47
-9.42%-0.50
24.05%-0.45
19.71%-0.46
10.02%-0.43
-10.14%-0.46
-61.14%-0.60
79.45%-0.57
88.37%-0.48
---0.41
-14.62%-0.37
---2.80
---4.11
---0.32
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Rallybio Corp's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing RLYB stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Rallybio Corp's revenue at year end?

Rallybio Corp reported 858.00K in revenue for fiscal year 2025, up from 636.00K in the previous year.

How much revenue did Rallybio Corp report in the most recent quarter?

Rallybio Corp reported 212.00K in revenue for the most recent quarter, an increase of 0.00% year over year.

What was Rallybio Corp's net income for the year?

Rallybio Corp posted -8.98M in net income for fiscal year 2025.

How much net income did Rallybio Corp post in the last quarter?

Rallybio Corp reported -8.28M in net income for the latest quarter。

What was Rallybio Corp's annual operating profit?

Rallybio Corp's operating income was -33.06M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.